Home/All Molecules/Sertaconazole

Sertaconazole Range

Comprehensive Sertaconazole portfolio for Franchise & Manufacturing.

Category
sertaconazole
Total Formulations
1
Available Forms
Cream

Expand Your Business with Our Multiple Divisions


Browse Sertaconazole portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Sertaconazole batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Sertaconazole PCD Pharma Franchise

Sertaconazole PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Sertaconazole PCD pharma franchise company offering a portfolio of 1 Sertaconazole formulations across cream. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Sertaconazole?

Sertaconazole is a topical imidazole antifungal with an added benzothiophene ring. It inhibits fungal ergosterol synthesis and, at higher concentrations, disrupts the fungal membrane directly; it also has intrinsic anti-inflammatory and antipruritic activity, which distinguishes it from older imidazoles. The compound record can be reviewed on PubChem.

Therapeutic Applications

Topical treatment of dermatophyte infections including tinea corporis, tinea cruris and tinea pedis, and of cutaneous candidiasis and pityriasis versicolor. Its antipruritic effect is useful where itching dominates the presentation.

Prescribed by: Dermatologists are the principal prescribers of Sertaconazole, with general physicians and paediatricians treating common tinea and candidal infections.

Why Sertaconazole is a High-Potential Molecule for Distributors

Recurrent and treatment-resistant dermatophytosis has become one of the defining problems of Indian dermatology, and prescribers are actively moving away from older topical imidazoles toward agents that both clear the fungus and settle the itch. Sertaconazole fits that need directly, which is why it commands a premium over clotrimazole and miconazole creams. Courses run for weeks and relapse is common, so repeat purchase is high, and dermatology remains a fast-growing, high-margin prescription segment for distributors.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Sertaconazole franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Sertaconazole business in your region.

References

  1. PubChem – Sertaconazole compound record, US National Library of Medicine
  2. PubMed – clinical literature on Sertaconazole, NCBI

Aceclofenac in Modern Clinical Practice

Our formulations of Sertaconazole find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Sertaconazole in PCD Franchise

Start Your Sertaconazole Franchise with Cafoli Lifecare

Ready to take monopoly rights for Sertaconazole in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 1 Sertaconazole formulations in cream. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Sertaconazole range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

Dermatologists are the principal prescribers of Sertaconazole, with general physicians and paediatricians treating common tinea and candidal infections.

Besides inhibiting ergosterol synthesis, Sertaconazole disrupts the fungal membrane directly and has intrinsic anti-inflammatory and antipruritic activity, so it relieves itching alongside clearing the infection. In the current Indian context of widespread recurrent tinea, that combination is why dermatologists increasingly select it over older topical imidazoles despite the higher price point.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Sertaconazole franchise agreement and monopoly allotment can be processed.